Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Directorate Changes

23 Oct 2012 11:00

RNS Number : 3090P
Arden Partners plc
23 October 2012
 



October 23rd, 2012

 

 

Arden Partners plc ("Arden" or the "Company")

 

Board Changes

 

Arden Partners plc, the AIM listed small/mid cap institutional broker today announces a number of changes to its Board and Executive Management responsibilities which will provide a more focussed business structure. The changes reduce the size of the Board to a level which is perhaps more relevant to a company of this size.

 

Non-Executive Chairman, Lord Flight, of Worcester, will shortly be stepping down from the Board in order to devote more time to other business and political interests. It is expected that this departure will be effective from 31st December 2012,

 

Also with effect from 31st, December 2012, following an appropriate handover process, Trevor Norris, Group Finance Director and Company Secretary, will also be retiring from the Board and leaving the Company with a view to expanding his other business ventures.

 

As a consequence of these departures the following changes to the roles of other Directors are being made, with effect from 1st January 2013.

 

·; Peter Moon, Non-Executive Director will become Non-Executive Chairman (designate). Peter will also serve as Chairman of the Remuneration and Nominations Committees.

 

·; Mark Ansell remains the Senior Independent Non-Executive Director and continues in this role and in his position as Chairman of the Audit Committee.

 

·; Jonathan Keeling, Chief Executive Officer, will become Executive Deputy Chairman, with specific responsibility for developing Arden's Global reach.

 

·; James Reed-Daunter, Executive Director, is to become Chief Executive Officer (designate).

 

·; Steve Wassell continues as Chief Operating Officer (COO) and adds the role of Company Secretary.

 

·; Financial reporting to the Board becomes the responsibility of Arden's current Financial Controller, who will report to the COO on a day to day basis.

 

It is anticipated that the revised board structure will enable Jonathan to spend more time on his Global responsibilities leaving James to take control of managing the business.

 

 

Jonathan Keeling commented:

 

"I would like to thank Lord Flight for having chaired the business through what has been a difficult period for our industry. In stepping down he has played an active and major part in the restructuring of the business and the Board and we very much appreciate his contribution in this regard.

 

I would also like to thank Trevor Norris for his long and loyal service to Arden Partners since its inception.

 

Lord Flight commented:

 

"I have enjoyed working with Jonathan Keeling who has done a great job in establishing and sustaining Arden's Indian corporate business. I believe there is major potential to expand Arden's international business and it must be right for Jonathan to be freed up to concentrate on this.

 

I think James Reed-Daunter is the right man to take over as Chief Executive to manage both the Arden team and the cost base.

 

I congratulate Arden for remaining in strong shape in a difficult business environment and wish the Company every success going forward."

 

The above appointments, where appropriate, are subject to FSA approval.

 

The Directors are mindful of their obligations with regard to maintaining good and progressive corporate governance.

 

Further info:

 

James Reed-Daunter

Jonathan Keeling

Arden Partners

020 7614 5900

Sam Fuller

Altium

020 7484 4037

Mark Edwards

Buchanan Communications

020 7466 5109

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMMZGLFLGZZG
Date   Source Headline
10th Feb 201110:04 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 201110:02 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 20114:28 pmRNSHolding(s) in Company
9th Feb 20114:28 pmRNSDirectors' Dealings
9th Feb 20114:27 pmRNSTransaction in own shares/Exercise of options/TVR
9th Feb 20119:32 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20119:17 amRNSForm 8.5 (EPT/NON-RI)
4th Feb 201110:36 amRNSForm 8.5 (EPT/NON-RI)
3rd Feb 201110:45 amRNSForm 8.5 (EPT/NON-RI)
2nd Feb 201110:09 amRNSForm 8.5 (EPT/NON-RI)
2nd Feb 201110:07 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 20113:55 pmRNSTotal Voting Rights
1st Feb 201111:41 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 201111:29 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20119:19 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20119:23 amRNSForm 8.5 (EPT/NON-RI)
24th Jan 201110:31 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20119:26 amRNSForm 8.5 (EPT/NON-RI)
20th Jan 20119:52 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 201111:17 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 201111:16 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20112:45 pmRNSForm 8.5 (EPT/NON-RI)
18th Jan 20117:00 amRNSPreliminary results
17th Jan 201111:01 amRNSForm 8.5 (EPT/NON-RI)
14th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20119:34 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20119:49 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20119:18 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 201110:18 amRNSForm 8.5 (EPT/NON-RI)
6th Jan 20119:25 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 20109:37 amRNSForm 8.5 (EPT/NON-RI)
30th Dec 201010:42 amRNSForm 8.5 (EPT/NON-RI)
24th Dec 201010:31 amRNSForm 8.5 (EPT/NON-RI)
23rd Dec 201011:03 amRNSChange of results announcement date
22nd Dec 20107:00 amRNSBoard changes
17th Dec 20109:25 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 201011:36 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 201010:00 amRNSDirector's declaration
10th Dec 20107:00 amRNSBoard change
7th Dec 201011:28 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 201011:38 amRNSForm 8.5 (EPT/NON-RI)
22nd Nov 20107:02 amRNSTotal Voting Rights
22nd Nov 20107:00 amRNSBlocklisting Return
15th Nov 20103:14 pmRNSHolding(s) in Company
12th Nov 20103:29 pmRNSHolding(s) in Company
12th Nov 20107:00 amRNSDirectors dealings
10th Nov 20104:30 pmRNSHolding(s) in Company
10th Nov 20104:19 pmRNSDirector's Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.